News

Remote electrical neuromodulation device helps reduce migraine days
- Author:
- Jeff Craven
Publish date: February 6, 2023
News
Brepocitinib improves symptoms of mild to moderate AD in phase 2b trial
- Author:
- Jeff Craven
Publish date: November 28, 2022
News
ICD-10 code can identify patients with melasma for future study
- Author:
- Jeff Craven
Publish date: November 10, 2022
News
Immediate skin-to-skin contact after cesarean section improves outcomes for parent, newborn
- Author:
- Jeff Craven
Publish date: October 25, 2022
News

Health care providers should have higher suspicion for rare diseases
- Author:
- Jeff Craven
Publish date: October 15, 2022
News

Headache for inpatients with COVID-19 may predict better survival
- Author:
- Jeff Craven
Publish date: October 13, 2022
News
Body-brain neuroinflammation loop may cause chronic ME/CFS, long COVID symptoms
- Author:
- Jeff Craven
Publish date: July 25, 2022
News
Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD
- Author:
- Jeff Craven
Publish date: July 11, 2022
News
Therapeutic patient education can help with adherence to treatment
- Author:
- Jeff Craven
Publish date: June 9, 2022
News
Steroid phobia drives weaker prescribing, nonadherence for AD
- Author:
- Jeff Craven
Publish date: May 9, 2022
News

Repurposed drug could revolutionize stem cell transplantation
- Author:
- Jeff Craven
Publish date: March 18, 2022
News
Early treatment may delay atherosclerosis in familial hypercholesterolemia
- Author:
- Jeff Craven
Publish date: March 7, 2022
News

Health disparities exist all over rheumatology: What can be done?
- Author:
- Jeff Craven
Publish date: February 28, 2022
News
Rheumatology patients seek guidance on CBD, cannabis products
- Author:
- Jeff Craven
Publish date: February 25, 2022
News

Treat-to-target in RA: Questions remain about adoption, measurement
- Author:
- Jeff Craven
Publish date: February 22, 2022